---
created: '2026-02-09T05:54:32.264623Z'
description: '...'
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/gene/stat3/
slug: stat3
tags:
- gene
- inflammation
- immune_system
- cancer_biology
- imported
- primekg
templateEngineOverride: njk
title: STAT3
type: gene
updated: '2026-02-09T05:54:32.264623Z'
---

{% raw %}
<h1>&quot;STAT3&quot;</h1>
<h2>Overview</h2>
<p><strong>STAT3</strong> (Signal Transducer and Activator of Transcription 3) is a member of the STAT protein family. It acts as both a cytoplasmic signaling messenger and a nuclear transcription factor.</p>
<p>Upon phosphorylation by JAK kinases (in response to cytokines like <strong>IL-6</strong>) or growth factor receptors, STAT3 dimerizes, translocates to the nucleus, and drives the expression of genes involved in cell survival, proliferation, and immune suppression.</p>
<h2>Biological Functions</h2>
<h3>1. Inflammation and Immunity</h3>
<ul>
<li><strong>Acute Phase Response:</strong> Drives the liver's production of acute-phase proteins (e.g., CRP) during inflammation.</li>
<li><strong>Th17 Differentiation:</strong> Essential for the development of Th17 helper T-cells, crucial for fighting fungal infections.</li>
<li><strong>Immune Suppression:</strong> In the tumor microenvironment, STAT3 inhibits the activity of dendritic cells and promotes regulatory T-cells (Tregs), helping tumors evade the immune system.</li>
</ul>
<h3>2. Cell Survival</h3>
<ul>
<li>Upregulates anti-apoptotic genes (like <em>BCL2</em>, <em>BCL-XL</em>, <em>MCL1</em>), preventing cell death.</li>
</ul>
<h2>Clinical Significance</h2>
<ul>
<li><strong>Cancer:</strong> STAT3 is constitutively activated (always &quot;on&quot;) in diverse cancers (breast, prostate, melanoma, leukemia). It drives tumor growth, metastasis, and drug resistance.</li>
<li><strong>Hyper-IgE Syndrome (Job's Syndrome):</strong> Caused by dominant-negative mutations in STAT3. Characterized by eczema, recurrent staphylococcal lung infections, and extremely high IgE levels due to Th17 deficiency.</li>
<li><strong>Autoimmunity:</strong> Gain-of-function mutations lead to early-onset autoimmunity.</li>
</ul>
<h2>Relationships</h2>
<p>ENCODES::[[STAT3 Protein]]<br />
ACTIVATED_BY::[[IL-6]] - Primary cytokine activator<br />
ACTIVATED_BY::[[JAK2]] - Upstream kinase<br />
ACTIVATED_BY::[[EGFR]]<br />
PARTICIPATES_IN_PATHWAY::[[JAK-STAT Pathway]]<br />
REGULATES::[[Inflammation]]<br />
REGULATES::[[Th17 Cells]]<br />
ASSOCIATED_WITH_CONDITION::[[Cancer]] - Promotes survival/metastasis<br />
ASSOCIATED_WITH_CONDITION::[[Hyper-IgE Syndrome]] - Loss of function<br />
ASSOCIATED_WITH_CONDITION::[[Psoriasis]] - Driven by Th17/STAT3 axis<br />
TARGETS::[[BCL2]] - Anti-apoptotic gene<br />
TARGETS::[[VEGF]] - Angiogenesis gene</p>
<h2>References</h2>
<ul>
<li>Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14(11):736-46.</li>
<li>Holland, S. M., et al. (2007). STAT3 mutations in the hyper-IgE syndrome. New England Journal of Medicine, 357(16), 1608-1619.</li>
</ul>

{% endraw %}